Sionna Therapeutics, Inc. (SION)
NASDAQ: SION · Real-Time Price · USD
6.06
-0.11 (-1.78%)
At close: Aug 27, 2026, 4:00 PM EDT
6.03
-0.03 (-0.50%)
After-hours: Aug 27, 2026, 7:48 PM EDT

Sionna Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Income
-109.49-88.98-70.56-50.33-41.37
Net Income
-97.38-75.27-61.69-47.26-40.24
Earnings Per Share
-2.17-1.88-15.99-16.11-15.61
EPS Growth
-----

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
268.25310.3168.0438.5282.61
Total Debt
8.078.689.7510.48-
Net Cash (Debt)
260.18301.63158.2928.0482.61
Net Cash Growth
-20.68%90.55%464.45%-66.05%-
Net Cash Per Share
5.797.5541.029.5632.05

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-75.92-66.3-52.79-43.7-36.07
Capital Expenditures
-0.29-0.38-0.03-1.12-1.87
Free Cash Flow
-76.21-66.67-52.81-44.82-37.94
Free Cash Flow Growth
-----

Valuation

Selected indicators aren't available for this stock.